• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
ZHAO Youhong, YANG Yang, XIE Zhishen, XU Xiaojun, LIU Li. Protective effects of Jinqi Jiangtang tablets on diabetic complications of cardiovascular diseases in Drosophila[J]. Journal of China Pharmaceutical University, 2016, 47(3): 348-352. DOI: 10.11665/j.issn.1000-5048.20160317
Citation: ZHAO Youhong, YANG Yang, XIE Zhishen, XU Xiaojun, LIU Li. Protective effects of Jinqi Jiangtang tablets on diabetic complications of cardiovascular diseases in Drosophila[J]. Journal of China Pharmaceutical University, 2016, 47(3): 348-352. DOI: 10.11665/j.issn.1000-5048.20160317
shu

Protective effects of Jinqi Jiangtang tablets on diabetic complications of cardiovascular diseases in Drosophila

More Information
    Graphical Abstract
    • Abstract
  • This study was to investigate the protective effects of Jinqi Jiangtang tablets on diabetic complications of cardiovascular disease in Drosophila. The effects of Jinqi Jiangtang tablets on hypolipidemia and hypoglycemia by high fat diet(HFD)induced model organism Drosophila with the content of triglyceride and trehalose in Drosophila as indexes, were investigated. And the Drosophila heart function was detected by high speed EM-CCD; cell signaling pathways were detected by Western blot and RT-PCR. The results showed that high fat diet could induce the appearance of hyperglycemia and hyperlipidemia on Drosophila model. Jinqi Jiangtang tablets could significantly reduce triglyceride and trehalose and protect heart function of Drosophila induced by high fat diet. Jinqi Jiangtang tablets could also increase the expression of 4ebp mRNA, while decreasing p-4EBP protein and pepck mRNA expression. This study demonstrated that Jinqi Jiangtang tablets have a protective effect on HFD-induced dyslipidemic-diabetic and cardiac dysfunction, which may be related to mTOR/4EBP pathway.
    • FullText(HTML)
    • References (12)
  • [1]
    Peng JL,Yin P,Wang B, et al.Efficacy and safety of Jinqi Jiangtang tablet in treatment of type 2 diabetes mellitus[J].Her Med(医药导报),2013,32(6):796-800.
    [2]
    Lakovaara S, Hackman W, Vepsalainen K. Malt as a culture medium for Drosophila species[J].Drosophila Inform Serv,1969,44:128.
    [3]
    Xu X,Gopalacharyulu P,Seppanen-Laakso T, et al.Insulin signaling regulates fatty acid catabolism at the level of CoA activation[J].PLoS Genetics,2012,8(1):e1002478.
    [4]
    Ocorr K,Reeves NL,Wessells RJ, et al.KCNQ potassium channel mutations cause cardiac arrhythmias in Drosophila that mimic the effects of aging[J].Proc Natl Acad Sci U S A,2007,104(10):3943-3948.
    [5]
    Zhu J,Jin X,Rei J, et al.Protection effect of new technological Jin Qi Jiang Tang tablets on rat pancreatic islet cells[J].Acta Acad Med CPAF(武警医学院学报),2010,19(6):437-441.
    [6]
    Yang FY,Yu J,Luo G, et al.The effect of new technological Jin Qi Jiang Tang tablets on rat glucose and lipid metabolism[J].Lishizhen Med Mater Med Res(时珍国医国药),2012,23(3):677-678.
    [7]
    Wang R,Wu J.Research progress on the effect of Jinqi Jiangtang tablet on protecting vascular endothelium diabetic nephropathy and insulin resistance[J].World Chin Med(世界中医药),2014,9(2):261-263.
    [8]
    Zheng N,Wei SJ.Protective effect of Jin Qi Jiang Tang tablets on kidney in diabetic rats[J].Tianjin J Tradit Chin Med(天津中医药),2014,31(4):226-230.
    [9]
    Laplante M,Sabatini DM.mTOR signaling at a glance[J].J Cell Sci, 2009,122(20):3589-3594.
    [10]
    Harris TE,Lawrence JC Jr.TOR signaling[J].Sci STKE,2003,2003(212):re 15.
    [11]
    Zhang HM, Fu J, Hamilton R, et al. The mammalian target of rapamycin modulates the immunoproteasome system in the heart[J].J Mol Cell Cardiol, 2015,86:158-167.
    [12]
    Johnson SC,Rabinovitch PS,Kaeberlein M.mTOR is a key modulator of ageing and age-related disease[J].Nature,2013,493(7432):338-345.
    • Related Articles

  • Related Articles

    [1]WU Lingxi, DU Yixuan, GAO Xiangdong. Inhibitory effect of IL-27 on the overactivation of microglia[J]. Journal of China Pharmaceutical University, 2024, 55(6): 801-808. DOI: 10.11665/j.issn.1000-5048.2024022702
    [2]WANG Sibu, CHEN Ying, DING Yang, XIAO Ting, LIU Wen, SHEN Xiangchun, TAO Ling, LUO Xinghong. Preparation of paeonol nanoemulsion and investigation of vascular endothelial cells uptake[J]. Journal of China Pharmaceutical University, 2022, 53(6): 690-697. DOI: 10.11665/j.issn.1000-5048.20220607
    [3]ZHANG Wendian, CUI Jie, XIA Yifan, ZHANG Xin, DUAN Shaofeng. Synthesis of two folate conjugates and their targeting effect in vitro[J]. Journal of China Pharmaceutical University, 2021, 52(4): 447-454. DOI: 10.11665/j.issn.1000-5048.20210407
    [4]WANG Xiaoying, WANG Xiaying, QIU Liangzhen, OUYANG Huizhi, XU Wei. Cytotoxicity and cellular uptake of paclitaxel-loaded carboxymethyl chitosan-rhein polymeric micelles in MCF-7 cells[J]. Journal of China Pharmaceutical University, 2020, 51(1): 33-37. DOI: 10.11665/j.issn.1000-5048.20200106
    [5]XU Wanyi, QIAO Jianbin, MA Bo, WANG Ran, QIAN Wen, LU Weidong. Cellular immunity of influenza vaccine lyophilized liposome produced by freeze-thawing[J]. Journal of China Pharmaceutical University, 2015, 46(6): 730-733. DOI: 10.11665/j.issn.1000-5048.20150616
    [6]CHEN Zhipeng, ZHANG Liujie, HE Jiayu, FENG Changhua, ZHAO Xiaoyi, ZHAO Can, CHENG Tiefeng. Cellular uptake of Brucine-loaded chitosan nanoparticles on human hepatic cancer cells in vitro[J]. Journal of China Pharmaceutical University, 2014, 45(6): 674-680. DOI: 10.11665/j.issn.1000-5048.20140610
    [7]LI Wenting, WANG Lu, ZHANG Can. Influence of surface characteristics on hepatocellular carcinoma cells uptake of nano-liposomes[J]. Journal of China Pharmaceutical University, 2013, 44(3): 244-248. DOI: 10.11665/j.issn.1000-5048.20130311
    [8]Bifendate liposomes modified by bile and its role in enhancing hepatocytes uptake in vitro[J]. Journal of China Pharmaceutical University, 2010, 41(4): 342-347.
    [9]SHAO Jing-ping, ZHANG Shan-fei, CHEN Yuan-cheng, YANG Wen-liang, LIU Xiao-quan. Cellular uptake characteristics of salvianolic acid B in myocardial cells and blood vessel endothelial cells[J]. Journal of China Pharmaceutical University, 2009, 40(3): 263-268.
    [10]Preparation of Brush Border Membrane Vesicles and Preliminary Studies on the Uptake of 5-FU[J]. Journal of China Pharmaceutical University, 2001, (6): 23-25.

  • Cited by

    Periodical cited type(6)

    1. 万瑞融，王希斌. CTLA-4纳米抗体与肿瘤适配体共修饰的双靶向脂质体构建. 医学理论与实践. 2024(01): 5-7+38 .
    2. 李建安，陈慧华，杨兰平，文玲波，贾燕华. 靶向药物和通路抑制剂治疗复发难治性B细胞非霍奇金淋巴瘤的研究进展. 广西医学. 2022(14): 1653-1656 .
    3. 陈敏，方翼. 双特异性抗体的免疫原性. 中国临床药理学与治疗学. 2021(10): 1208-1212 .
    4. 刘婧琳，吴春暖，宋晓坤. 抗肿瘤药物临床超常用药分析. 中国药房. 2020(07): 873-878 .
    5. 赵秋玲，杨琳，谢瑞祥. 9种获批上市的抗PD-1/PD-L1单抗药物的特征综述. 中国药房. 2020(18): 2294-2299 .
    6. 辛中帅，张彦彦，晋小雁，杨建红. 我国已上市治疗用单抗类产品分析. 中国药事. 2019(09): 986-990 .

    Other cited types(2)

Catalog

    Get Citation
    PDF
    XML
    Article views (1174) PDF downloads (2251) Cited by(8)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：292652

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return